- Home
- IMNM vs THRY Comparison
IMNM vs THRY Comparison
Compare IMNM & THRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- THRY
- Stock Information
- Founded
- IMNM 2006
- THRY 2012
- Country
- IMNM United States
- THRY United States
- Employees
- IMNM N/A
- THRY N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- THRY Industrial Machinery/Components
- Sector
- IMNM Health Care
- THRY Industrials
- Exchange
- IMNM Nasdaq
- THRY Nasdaq
- Market Cap
- IMNM 770.1M
- THRY 587.3M
- IPO Year
- IMNM 2020
- THRY 2020
- Fundamental
- Price
- IMNM $7.46
- THRY $13.75
- Analyst Decision
- IMNM Strong Buy
- THRY Strong Buy
- Analyst Count
- IMNM 5
- THRY 5
- Target Price
- IMNM $26.40
- THRY $21.40
- AVG Volume (30 Days)
- IMNM 1.1M
- THRY 710.0K
- Earning Date
- IMNM 05-16-2025
- THRY 05-01-2025
- Dividend Yield
- IMNM N/A
- THRY N/A
- EPS Growth
- IMNM N/A
- THRY N/A
- EPS
- IMNM N/A
- THRY N/A
- Revenue
- IMNM $9,041,000.00
- THRY $771,903,000.00
- Revenue This Year
- IMNM N/A
- THRY N/A
- Revenue Next Year
- IMNM $1,259.12
- THRY N/A
- P/E Ratio
- IMNM N/A
- THRY N/A
- Revenue Growth
- IMNM N/A
- THRY N/A
- 52 Week Low
- IMNM $5.15
- THRY $10.03
- 52 Week High
- IMNM $19.07
- THRY $26.42
- Technical
- Relative Strength Index (RSI)
- IMNM 43.56
- THRY 55.04
- Support Level
- IMNM $7.15
- THRY $13.08
- Resistance Level
- IMNM $9.16
- THRY $14.15
- Average True Range (ATR)
- IMNM 0.51
- THRY 0.83
- MACD
- IMNM -0.08
- THRY 0.21
- Stochastic Oscillator
- IMNM 15.42
- THRY 84.31
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About THRY Thryv Holdings Inc.
Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. Its company is built upon a rich legacy in the marketing and advertising industry. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable SMB clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation, and run their day-to-day operations to save time, compete and win in today's SMB environment. The group has two business segments; Thryv SaaS and Thryv Marketing Services.